Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: LACOSAMIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved lacosamide as an original application (ANDA) for Amneal Pharmaceuticals of New York LLC, making a generic lacosamide available for seizure treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)